Senphonix wins NSF grant to advance continuous vitals-monitoring wearable
What's the deal? SenphonixDealroom has a profile for this one. Try Dealroom →, a Tucson-based medical-technology startup, has received a Small Business Technology Transfer (STTR) Phase I award from the National Science Foundation through America's Seed FundDealroom has a profile for this one. Try Dealroom →. The grant supports engineering on SleeveSense, a wearable sleeve designed to continuously monitor patients' vital signs over days, weeks, or months.
What's the endgame? SleeveSense is a comfortable sleeve worn during a hospital stay and after discharge, streaming multiple vital signs continuously. The company aims to remove manual measurements, flag patient deterioration earlier, and give clinicians a fuller picture after discharge.
Why now? Vital signs are typically captured as periodic spot checks, and nurses can spend more than 20% of every shift measuring them manually. The award funds work on the patent-pending device's wireless and radio-frequency systems — including its antenna and power performance in real hospital settings — to move it from prototype toward scale manufacturing.
The engineering work is being done in partnership with the University of ArizonaDealroom has a profile for this one. Try Dealroom →. Senphonix plans to go to market in 2027.
What did they say? "This award is significant validation of the critical needs SleeveSense will address," said Mike Haldane, co-founder and co-CEO. "NSF's support lets us further engineer the technology as we prepare to go to market in 2027."
The backstory: The federal grant builds on earlier matching funding from the Arizona Commerce AuthorityDealroom has a profile for this one. Try Dealroom →, through the WearTech Applied Research CenterDealroom has a profile for this one. Try Dealroom →, which backed the company's early design work. Founder and private funding continue to support its Arizona-based research.
The signal: Continuous monitoring aims to replace intermittent spot checks that consume clinician time and can miss early warning signs. Federal and state backing points to growing institutional interest in wearables that follow patients from the hospital into the home.
Image credit: Generated with Gemini
